Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor

Bioorganic & Medicinal Chemistry Letters
2002.0

Abstract

This communication describes the synthesis and in vitro evaluation of a novel and potent series of phthalazine phosphodiesterase type (IV) (PDE4) inhibitors. The interaction with two distinct polar binding sites allowed us to eliminate the cyclopentyloxy substitution from rolipram-like analogues.

Knowledge Graph

Similar Paper

Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
Bioorganic & Medicinal Chemistry Letters 2002.0
Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
Bioorganic & Medicinal Chemistry Letters 2001.0
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
Bioorganic & Medicinal Chemistry Letters 2000.0
Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated affinity for the [3H]rolipram binding site
Bioorganic & Medicinal Chemistry Letters 1995.0
Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles
Bioorganic & Medicinal Chemistry Letters 1995.0
Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors
Journal of Medicinal Chemistry 1997.0
Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure−Activity Relationships of 4-Aryl-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
Journal of Medicinal Chemistry 2001.0
The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I
Bioorganic & Medicinal Chemistry Letters 1998.0
Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines
Bioorganic & Medicinal Chemistry Letters 1995.0